Publications by authors named "Alex Torres Acosta"

Claim this Profile
I
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Elisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, Chandra Adhikari, Carolien Bierman, Alex Torres Acosta

Lancet Oncolยท July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis